These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11775846)

  • 21. Biotechnology: an introduction to recombinant DNA technology and product availability.
    Evens RP; Witcher M
    Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of new vaccine technologies for the control of transboundary diseases.
    Swayne DE
    Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China.
    Zhou LG; Wu JY
    Nat Prod Rep; 2006 Oct; 23(5):789-810. PubMed ID: 17003910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of ophthalmic projects granted by National Natural Science Foundation].
    Shao JJ; Mo XF; Pan ZQ; Gan DK; Xu YY
    Zhonghua Yan Ke Za Zhi; 2008 Sep; 44(9):839-44. PubMed ID: 19175165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the individual and the community in the research, development, and use of biologicals with criteria for guidelines: a memorandum.
    Bull World Health Organ; 1976; 54(6):645-55. PubMed ID: 1088511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Today's regional distribution of echinococcosis in China.
    Jiang C
    Chin Med J (Engl); 2002 Aug; 115(8):1244-7. PubMed ID: 12515272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of biologicals produced in continuous cell lines.
    Hoffman T; Fratantoni J; Murano G
    Dev Biol Stand; 1989; 70():211-4. PubMed ID: 2668073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contemporary vaccinology--scientific and practical aspects].
    Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R
    Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The French Journal of Stomatology and Maxillofacial Surgery: what is the future?].
    Bettega G
    Rev Stomatol Chir Maxillofac; 2001 Nov; 102(6):295-7. PubMed ID: 11862897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How the research-based industry approaches vaccine development and establishes priorities.
    André FE
    Dev Biol (Basel); 2002; 110():25-9. PubMed ID: 12477303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biotechnology for the benefit of vaccination against viral diseases: a review].
    van Oirschot JT
    Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comprehensive evaluation of the Chinese Journal of Hepatology (Zhonghua Ganzangbing Zazhi) from 1999 to 2003].
    Jin S; Zhang DZ; Ren H; Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):218-20. PubMed ID: 15760560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of natural products to future pharmaceutical discovery.
    Baker DD; Chu M; Oza U; Rajgarhia V
    Nat Prod Rep; 2007 Dec; 24(6):1225-44. PubMed ID: 18033577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.